@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix schem: . @prefix mesh: . @prefix RNA: . @prefix mgi: . @prefix geneProductOf: . @prefix obo: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 geneProductOf: mgi:96163; a RNA: . sub:_2 rdf:object sub:_1; rdf:predicate belv:increases; rdf:subject mesh:D018496; a rdf:Statement . sub:_3 occursIn: obo:CLO_0001925, obo:CL_0000057, obo:UBERON_0002048, species:10090; rdf:object sub:_2; rdf:predicate belv:decreases; rdf:subject schem:SB-202190; a rdf:Statement . sub:assertion rdfs:label "a(SCHEM:\"SB-202190\") -| (path(MESHD:Hyperoxia) -> r(MGI:Hmox1))", "path(MESHD:Hyperoxia) -> r(MGI:Hmox1)" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_5; pav:version "20131211" . sub:_4 prov:value "pretreatment with SB202190, a chemical inhibitor of p38 MAPK, reduced the apparent elevation in hyperoxia-inducible HO-1 expression in cav-1-/- cells, relative to vehicle controls (DMSO)."; prov:wasQuotedFrom pubmed:18323531 . sub:_5 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:18323531; prov:wasDerivedFrom beldoc:, sub:_4 . } sub:pubinfo { this: dct:created "2014-07-03T14:33:18.535+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }